Electronic Resource
[s.l.]
:
Nature Publishing Group
Nature biotechnology
19 (2001), S. 696-697
ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] At the World Congress of Neurology in London on June 22, Serono presented data from a head-to-head trial (the EVIDENCE trial) of its own product Rebif and Biogen's (Cambridge, MA) Avonex, both interferon β-1a products to treat relapsing-remitting multiple sclerosis (MS). Patients treated with ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/90716
Permalink
|
Location |
Call Number |
Expected |
Availability |